Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, has received a second 510(k) clearance (K181895) for its new Kurin® PIV18 peripheral IV configuration with an extension set, which can be used for infusion.
Kurin, Inc. Announces Clinical Results on Kurin® Efficacy from Central Texas Veterans Health Care System
Kurin, Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today that the Temple VA Hospital in Temple, TX, presented their findings comparing results of Kurin and Magnolia Medical’s Steripath at the recent Southwest Association of Clinical Microbiology.
Spinal Singularity announced that the company was awarded a Phase II SBIR grant from the National Institute of Health (NIH). The grant will provide approximately $1.5 Million in non-dilutive funding to continue clinical development of the Connected Catheter 2P (C2P).